New Nicotine Alliance UK. https://nnalliance.org/snus-facts. Accessed 13 Feb 2019.
The European Parliament and the Council of the European Union. Directive 2014/40/EU of the European Parliament and of the Council of 3 April 2014 on the approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco and related products and repealing Directive 2001/37/EC. 2014. https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=celex%3A32014L0040. Accessed 20 Feb 2019.
http://curia.europa.eu/juris/document/document.jsf;jsessionid=2A1C83343A360F2FB84838F0E797BAD0?text=&docid=207969&pageIndex=0&doclang=en&mode=req&dir=&occ=first&part=1&cid=2420873. Accessed 17th July 2019.
International Agency for Research on Cancer. Smokeless tobacco and some tobacco-specific N-nitrosamines. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Volume 89. 2007. https://monographs.iarc.fr/wp-content/uploads/2018/06/mono89.pdf. Accessed 07 Feb 2019.
Rutqvist LE, Curvall M, Hassler T, Ringberger T, Wahlberg I. Swedish snus and the GothiaTek® standard. Harm Reduct J. 2011;8:11.
Article
PubMed
PubMed Central
Google Scholar
Royal College of Physicians. Nicotine without smoke: tobacco harm reduction. 2016. https://www.rcplondon.ac.uk/projects/outputs/nicotine-without-smoke-tobacco-harm-reduction-0. Accessed 11 Feb 2019.
Rodu B, Jansson JH, Eliasson M. The low prevalence of smoking in the Northern Sweden MONICA study, 2009. Scand J Public Health. 2013;41:808–11.
Article
PubMed
Google Scholar
Public Health Agency of Sweden. The National Survey of Public Health: Tobacco. 2016. https://www.folkhalsomyndigheten.se/folkhalsorapportering-statistik/statistikdatabaser-och-visualisering/nationella-folkhalsoenkaten/resultat-a-o/. Accessed 06 Feb 2018.
The European Commission. Special Eurobarometer 458. Attitudes of Europeans towards tobacco and electronic cigarettes. 2017. http://ec.europa.eu/commfrontoffice/publicopinion/index.cfm/Survey/getSurveyDetail/instruments/SPECIAL/surveyKy/2146. Accessed 20 Feb 2019.
Wettergreen, J. Statistisk sentralbyrå. 2019. https://www.ssb.no/en/helse/artikler-og-publikasjoner/snus-and-cigarettes-equally-popular. Accessed 28 Feb 2019.
Wettergreen, J. Statistisk sentralbyriå. 2018. https://www.ssb.no/en/helse/artikler-og-publikasjoner/snus-more-used-than-cigarettes. Accessed 19 Jan 2018.
Global Tobacco Surveillance System Data. Centers for Disease Control and Prevention. 2014. https://www.cdc.gov/tobacco/global/gtss/gtssdata/index.html. Accessed 28 Feb 2018.
World Health Organisation. WHO report on the Global Tobacco Epidemic, 2013: Enforcing bans on tobacco advertising, promotion and sponsorship. Geneva: 2013. https://www.who.int/tobacco/global_report/2013/en/. Accessed 24 Jan 2018.
Peto R, Darby S, Deo H, Silcocks P, Whitely E, Doll R. Smoking, smoking cessation and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ. 2000;321:323–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
The United States Surgeon General. 2010 Surgeon General’s report - how tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease. 2010. https://www.cdc.gov/tobacco/data_statistics/sgr/2010/index.htm. Accessed 04 Feb 2019.
International Agency for Research on Cancer. Personal habits and indoor combustions. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Volume 100E. 2012. https://monographs.iarc.fr/wp-content/uploads/2018/06/mono100E.pdf. Accessed 07 Feb 2019.
European Parliament. European Parliament News. 2016. http://www.europarl.europa.eu/news/en/headlines/society/20160518STO27901/700-000-deaths-a-year-tackling-smoking-in-the-eu. Accessed 24 Jan 2018.
World Health Organisation. Data and statistics. 2016. http://www.euro.who.int/en/health-topics/disease-prevention/tobacco/data-and-statistics. Accessed 24 Jan 2018.
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–403.
Article
CAS
PubMed
Google Scholar
Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2018). Global Cancer Observatory: cancer today. Lyon, France: International Agency for Research on Cancer. http://gco.iarc.fr/today/home. Accessed 21 Mar 2019.
Peto R, Lopez A, Boreham J, Thun M. Mortality from smoking in developed countries 1950-2000. Geneva: Internation Union Against Cancer; 2006. https://www.ctsu.ox.ac.uk/research/mortality-from-smoking-in-developed-countries-1950-2005-or-later. Accessed 22 Feb 2018.
Nutt DJ, Philips LD, Balfour D, Curran HV, Dockrell M, Foulds J, Fagerstöm K, Letlape K, Milton A, Polosa R, Ramsey J, Sweanor D. Estimating the harms of nicotine-containing products using the MDCA approach. Eur Addict Res. 2014;20:218–25.
Article
PubMed
Google Scholar
Scientific Committee on Emerging and Newly Identified Health Risks. Health effects of smokeless tobacco products. 2008. http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_013.pdf. Accessed 18 Feb 2019.
Lee PN. Epidemiological evidence relating snus to health - an updated review based on recent publications. Harm Reduct J. 2013;10:36.
Article
CAS
PubMed
PubMed Central
Google Scholar
Royal College of Physicians. Harm reduction in nicotine addiction: helping people who can’t quit. 2007. https://cdn.shopify.com/s/files/1/0924/4392/files/harm-reduction-nicotine-addiction.pdf?15599436013786148553. Accessed 27 Feb 2019.
Levy DT, Mumford EA, Cummins KM, Gilpin EA, Giovino EA, Hyland A, Sweanor D, Warner KE. The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: Estimates of a panel of experts. Cancer Epidemiol Biomarkers Prev. 2004;13:2035–42.
CAS
PubMed
Google Scholar
Gartner CE, Hall WD, Vos T, Bertram MY, Wallace AL, Lim SS. Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study. Lancet. 2007;369:2010–4.
Article
PubMed
Google Scholar
Ramström L, Borland R, Wikmans T. Patterns of smoking and snus use in sweden: implications for public health. Int J Environ Res Public Health. 2016;13:E1110.
Article
PubMed
Google Scholar
Asplund K, Nasic S, Janlert U, Stegmayr B. Smokeless tobacco as a possible risk factor for stroke in men – a nested case-control study. Stroke. 2003;34:1754–9.
Article
PubMed
Google Scholar
Rodu B, Cole P. Lung cancer mortality: comparing Sweden with other countries in the European Union. Scand J Public Health. 2009;37:481–6.
Article
PubMed
Google Scholar
Luo J, Ye W, Zendehdel K, Adam J, Adami HO, Boffetta P, Nyrén O. Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet. 2007;369:2015–20.
Article
PubMed
Google Scholar
Boffetta P, Aagnes B, Weiderpass E, Andersen A. Smokeless tobacco use and risk of cancer of the pancreas and other organs. Int J Cancer. 2005;114:992–5.
Article
CAS
PubMed
Google Scholar
National Health Service. Cardiovascular disease. 2018. https://www.nhs.uk/conditions/cardiovascular-disease/. Accessed 16 Mar 2018.
Bolinder G, Alfredsson L, Englund A, de Faire U. Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Public Health. 1994;84:399–404.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hergens MP, Alfredsson L, Bolinder G, Lambe M, Pershagen G, Ye W. Long-term use of Swedish moist snuff and the risk of myocardial infarction amongst men. J Intern Med. 2007;262:351–9.
Article
PubMed
Google Scholar
Arefalk G, Hergens MP, Ingelsson E, Arnlöv J, Michaëlsson K, Lind L, Ye W, Nyrén O, Lambe M, Sundström J. Smokeless tobacco (snus) and risk of heart failure: results from two Swedish cohorts. Eur J Prev Cardiol. 2012;19:1120–7.
Article
PubMed
Google Scholar
Huhtasaari F, Asplund K, Lundberg V, Stegmayr B, Wester PO. Tobacco and myocardial infarction: is snuff less dangerous than cigarettes? BMJ. 1992;305:1252–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Huhtasaari F, Lundberg V, Eliasson M, Janlert U, Asplund K. Smokeless tobacco as a possible risk factor for myocardial infarction: a population-based study in middle-aged men. J Am Coll Cardiol. 1999;34:1784–90.
Article
CAS
PubMed
Google Scholar
Hergens MP, Ahlbom A, Andersson T, Pershagen G. Swedish moist snuff and myocardial infarction among men. Epidemiology. 2005;16:12–6.
Article
PubMed
Google Scholar
Haglund B, Eliasson M, Stenbeck M, Rosén M. Is moist snuff use associated with excess risk of IHD or stroke? A longitudinal follow-up of snuff users in Sweden. Scand J Public Health. 2007;35:618–22.
Article
PubMed
Google Scholar
Wennberg P, Eliasson M, Hallmans G, Johansson L, Boman K, Jansson JH. The risk of myocardial infarction and sudden cardiac death amongst snuff users with or without a previous history of smoking. J Intern Med. 2007;262:360–7.
Article
CAS
PubMed
Google Scholar
Janzon E, Hedblad B. Swedish snuff and incidence of cardiovascular disease. A population-based cohort study. BMC Cardiovasc Disord. 2009;9:21.
Article
PubMed
Google Scholar
Hansson J, Pedersen NL, Galanti MR, Andersson T, Ahlbom A, Hallqvist J, Magnusson C. Use of snus and risk for cardiovascular disease: results from the Swedish twin registry. J Intern Med. 2009;265:717–24.
Article
CAS
PubMed
Google Scholar
Hansson J, Galanti MR, Hergens MP, Fredlund P, Ahlbom A, Alfredsson L, Bellocco R, Eriksson M, Hallqvist J, Hedblad J, Jansson JH, Nilsson P, Pedersen N, Trolle Lagerros Y, Ostergren PO, Magnusson C. Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies. Eur J Epidemiol. 2012;27:771–9.
Article
PubMed
Google Scholar
Hergens MP, Galanti R, Hansson J, Fredlund P, Ahlbom A, Alfredsson L, Bellocco R, Erikssen M, Fransson EI, Hallqvist J, Jansson JH, Knutsson A, Pedersen N, Lagerros YT, Ostergren PO, Magnusson C. Use of Scandinavian moist smokeless tobacco (snus) and the risk of atrial fibrillation. Epidemiology. 2014;25:872–6.
Article
PubMed
Google Scholar
Hergens MP, Lambe M, Pershagen G, Terent A, Ye W. Smokeless tobacco and the risk of stroke. Epidemiology. 2008;19:794–9.
Article
PubMed
Google Scholar
Hansson J, Galanti MR, Hergens MP, Fredlund P, Ahlbom A, Alfredsson L, Bellocco R, Engström G, Eriksson M, Hallqvist J, Hedblad B, Jansson JH, Pedersen NL, Trolle Lagerros Y, Ostergren PO, Magnusson C. Snus (Swedish smokeless tobacco) use and risk of stroke: pooled analyses of incidence and survival. J Intern Med. 2014;276:87–95.
Article
CAS
PubMed
Google Scholar
Lee PN. Summary of the epidemiological evidence relating snus to health. Regul Toxicol Pharmacol. 2011;59:197–214.
Article
CAS
PubMed
Google Scholar
Hirsch JM, Hedner J, Wernstedt L, Lundberg J, Hedner T. Hemodynamic effects of the use of snuff. Clin Pharmacol Ther. 1992;52:394–401.
Article
CAS
PubMed
Google Scholar
Bolinder G, de Faire U. Ambulatory 24-h blood pressure monitoring in healthy, middle-aged smokeless tobacco users, smokers, and nontobacco users. Am J Hypertens. 1998;11:1153–63.
Article
CAS
PubMed
Google Scholar
Rohani M, Agewall S. Oral snuff impairs endothelial function in healthy snuff users. J Intern Med. 2004;255:379–83.
Article
CAS
PubMed
Google Scholar
Bolinder GM, Ahlborg BO, Lindell JH. Use of smokeless tobacco: blood pressure elevation and other health hazards found in a large-scale population survey. J Intern Med. 1992;232:327–34.
Article
CAS
PubMed
Google Scholar
Hergens MP, Lambe M, Pershagen G, Ye W. Risk of hypertension amongst Swedish male snuff users: a prospective study. J Intern Med. 2008;264:187–94.
Article
PubMed
Google Scholar
Sundström D, Waldenborg M, Emilsson K. Acute effects on the ventricular function in Swedish snuffers: an echocardiographic study. Clin Physiol Funct Imaging. 2012;32:106–13.
Article
PubMed
Google Scholar
Björkman F, Edin F, Mattsson CM, Larsen F, Ekblom B. Regular moist snuff dipping does not affect endurance exercise performance. PLoS One. 2017;12:e0181228.
Article
CAS
PubMed
PubMed Central
Google Scholar
Eliasson M, Lundblad D, Hägg E. Cardiovascular risk factors in young snuff users and cigarette smokers. J Intern Med. 1991;230:17–22.
Article
CAS
PubMed
Google Scholar
Wennmalm A, Benthin G, Granström EF, Persson L, Petersson AS, Winell S. Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men. Circulation. 1991;83:1698–704.
Article
CAS
PubMed
Google Scholar
Eliasson M, Asplund K, Evrin PE, Lundblad D. Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin. The Northern Sweden MONICA study. Atherosclerosis. 1995;113:41–53.
CAS
PubMed
Google Scholar
Wallenfeldt K, Hulthe J, Bokemark L, Wikstrand J, Fagerberg B. Carotid and femoral atherosclerosis, cardiovascular risk factors and C-reactive protein in relation to smokeless tobacco use or smoking in 58-year-old men. J Intern Med. 2001;250:492–501.
Article
CAS
PubMed
Google Scholar
Johansson SE, Sundquist K, Qvist J, Sundquist J. Smokeless tobacco and coronary heart disease a 12-year follow-up study. Eur J Cardiovasc Prev Rehabil. 2005;12:387–92.
Article
PubMed
Google Scholar
Norberg M, Stenlund H, Lindahl B, Boman K, Weinehall L. Contribution of Swedish moist snuff to the metabolic syndrome: a wolf in sheep's clothing? Scand J Public Health. 2006;34:576–83.
Article
PubMed
Google Scholar
Byhamre ML, Gustafsson PE, Jansson JH, Wennberg M, Hammarström A, Wennberg P. Snus use during the life-course and risk of the metabolic syndrome and its components. Scand J Public Health. 2017;45:733–40.
Article
PubMed
Google Scholar
Pancreatic Cancer UK. Risk factors for pancreatic cancer. 2018. https://www.pancreaticcancer.org.uk/information-and-support/facts-about-pancreatic-cancer/risk-factors-for-pancreatic-cancer/. Accessed 15 Mar 2018.
Araghi M, Rosaria Galanti M, Lundberg M, Lager A, Engström G, Alfredsson L, Knutsson A, Norberg M, Sund M, Wennberg P, Trolle Lagerros Y, Bellocco R, Pedersen NL, Östergren PO, Magnusson C. Use of moist oral snuff (snus) and pancreatic cancer: Pooled analysis of nine prospective observational studies. Int J Cancer. 2017;141:687–93.
Article
CAS
PubMed
Google Scholar
Sponsiello-Wang Z, Weitkunat R, Lee PN. Systematic review of the relation between smokeless tobacco and cancer of the pancreas in Europe and North America. BMC Cancer. 2008;8:356.
Article
PubMed
PubMed Central
Google Scholar
Lee PN, Hamling J. The relation between smokeless tobacco and cancer in Northern Europe and North America. A commentary on differences between the conclusions reached by two recent reviews. BMC Cancer. 2009;9:256.
Article
PubMed
PubMed Central
Google Scholar
Persson PG, Carlsson S, Svanström L, Ostenson CG, Efendic S, Grill V. Cigarette smoking, oral moist snuff use and glucose intolerance. J Intern Med. 2000;248:103–10.
Article
CAS
PubMed
Google Scholar
Eliasson M, Asplund K, Nasic S, Rodu B. Influence of smoking and snus on the prevalence and incidence of type 2 diabetes amongst men: the northern Sweden MONICA study. J Intern Med. 2004;256:101–10.
Article
CAS
PubMed
Google Scholar
Wändell PE, Bolinder G, de Faire U, Hellénius ML. Association between metabolic effects and tobacco use in 60-year-old Swedish men. Eur J Epidemiol. 2008;23:431–4.
Article
PubMed
Google Scholar
Neumann A, Norberg M, Schoffer O, Norström F, Johansson I, Klug SJ, Lindholm L. Risk equations for the development of worsened glucose status and type 2 diabetes mellitus in a Swedish intervention program. BMC Public Health. 2013;13:1014.
Article
PubMed
PubMed Central
Google Scholar
Rasouli B, Andersson T, Carlsson PO, Grill V, Groop L, Martinell M, Midthjell K, Storm P, Tuomi T, Carlsson S. Use of Swedish smokeless tobacco (snus) and the risk of Type 2 diabetes and latent autoimmune diabetes of adulthood (LADA). Diabet Med. 2017;34:514–21.
Article
CAS
PubMed
Google Scholar
Östenson CG, Hilding A, Grill V, Efendic S. High consumption of smokeless tobacco ("snus") predicts increased risk of type 2 diabetes in a 10-year prospective study of middle-aged Swedish men. Scand J Public Health. 2012;40:730–7.
Article
PubMed
Google Scholar
Carlsson S, Andersson T, Araghi M, Galanti R, Lager A, Lundberg M, Nilsson P, Norberg M, Pedersen NL, Trolle-Lagerros Y, Magnusson C. Smokeless tobacco (snus) is associated with an increased risk of type 2 diabetes: results from five pooled cohorts. J Intern Med. 2017;281:398–406.
Article
CAS
PubMed
Google Scholar
Lee PN, Thornton AJ. The relationship of snus use to diabetes and allied conditions. Regul Toxicol Pharmacol. 2017;91:86–92.
Article
PubMed
Google Scholar
Axell T. A prevalence study of oral mucosal lesions in an adult Swedish population. Odontol Revy Suppl. 1976;36:1–103.
CAS
PubMed
Google Scholar
Lewin F, Norell SE, Johansson H, Gustavsson P, Wennerberg J, Biörklund A, Rutqvist LE. Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck. A population-based case referent study in Sweden. Cancer. 1998;82:1367–75.
Article
CAS
PubMed
Google Scholar
Schildt EB, Eriksson M, Hardell L, Magnuson A. Oral snuff, smoking habits and alcohol consumption in relation to oral cancer in a Swedish case-control study. Int J Cancer. 1998;77:341–6.
Article
CAS
PubMed
Google Scholar
Rosenquist K, Wennerberg J, Schildt EB, Bladström A, Hansson BG, Andersson G. Use of Swedish moist snuff, smoking and alcohol consumption in the aetiology of oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol. 2005;125:991–8.
Article
PubMed
Google Scholar
Bundgaard T, Wildt J, Frydenberg M, Elbrønd O, Nielsen JE. Case-control study of squamous cell cancer of the oral cavity in Denmark. Cancer Causes Control. 1995;6:57–67.
Article
CAS
PubMed
Google Scholar
Roosaar A, Johansson AL, Sandborgh-Englund G, Axéll T, Nyrén O. Cancer and mortality among users and nonusers of snus. Int J Cancer. 2008;123:168–73.
Article
CAS
PubMed
Google Scholar
Hirsch JM, Wallström M, Carlsson AP, Sand L. Oral cancer in Swedish snuff dippers. Anticancer Res. 2012;10:3327–30.
Google Scholar
Food and Drug Administration. Perspective: lessons learned from the first review of modified risk tobacco product (MRTP) Applications. 2016. https://www.fda.gov/TobaccoProducts/Labeling/MarketingandAdvertising/ucm533753.htm. Accessed 09 Mar 2018.
Institute of Medicine. Clearing the smoke. Assessing the science base for tobacco harm reduction. 2001. https://www.nap.edu/read/10029/chapter/1. Accessed 07 Feb 2019.
https://www.nhs.uk/conditions/mouth-cancer/. Accessed 16th July 2019.
Kallischnigg G, Weitkunat R, Lee PN. Systematic review of the relation between smokeless tobacco and non-neoplastic oral diseases in Europe and the United States. BMC Oral Health. 2008;8:13.
Article
PubMed
PubMed Central
Google Scholar
Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin. 2002;52(4):195–215.
Article
PubMed
Google Scholar
https://www.nhs.uk/conditions/gum-disease/. Accessed 16th July 2019.
Modéer T, Lavstedt S, Xhlund C. Relation between tobacco consumption and oral health in Swedish schoolchildren. Acta Odontol Scand. 1980;38:233–7.
Google Scholar
Wickholm S, Söder PO, Galanti MR, Söder B, Klinge B. Periodontal disease in a group of Swedish adult snuff and cigarette users. Acta Odontol Scand. 2004;62:333–8.
Article
PubMed
Google Scholar
Rolandsson M, Hellqvist L, Lindqvist L, Hugoson A. Effects of snuff on the oral health status of adolescent males: a comparative study. Oral Health Prev Dent. 2005;3:77–85.
PubMed
Google Scholar
Bergström J, Keilani H, Lundholm C, Rådestad U. Smokeless tobacco (snuff) use and periodontal bone loss. J Clin Periodontol. 2006;33:549–54.
Article
PubMed
Google Scholar
Montén U, Wennström JL, Ramberg P. Periodontal conditions in male adolescents using smokeless tobacco (moist snuff). J Clin Periodontol. 2006;33:863–8.
Article
PubMed
Google Scholar
Andersson G, Axéll T. Clinical appearance of lesions associated with the use of loose and portion-bag packed Swedish moist snuff: a comparative study. J Oral Pathol Med. 1989;18:2–7.
Article
CAS
PubMed
Google Scholar
Frithiof L, Anneroth G, Lasson U, Sederholm C. The snuff-induced lesion. A clinical and morphological study of a Swedish material. Acta Odontol Scand. 1983;41:53–64.
Article
CAS
PubMed
Google Scholar
Hugoson A, Rolandsson M. Periodontal disease in relation to smoking and the use of Swedish snus: epidemiological studies covering 20 years (1983-2003). J Clin Periodontol. 2011;38:809–16.
Article
PubMed
Google Scholar
Hirsch JM, Livian G, Edward S, Noren JG. Tobacco habits among teenagers in the city of Göteborg, Sweden, and possible association with dental caries. Swed Dent J. 1991;15:117–23.
CAS
PubMed
Google Scholar
Hugoson A, Hellqvist L, Rolandsson M, Birkhed D. Dental caries in relation to smoking and the use of Swedish snus: epidemiological studies covering 20 years (1983-2003). Acta Odontol Scand. 2012;70:289–96.
Article
PubMed
Google Scholar
Hellqvist L, Rolandsson M, Hugoson A, Lindström P, Birkhed D. Dental caries and associated factors in a group of Swedish snus users. Swed Dent J. 2015;39:47–54.
PubMed
Google Scholar
Wetter DW, McClure JB, de Moor C, Cofta-Gunn L, Cummings S, Cinciripini PM, Gritz ER. Concommitant use of cigarettes and smokeless tobacco: prevalence, correlates, and predictors of tobacco cessation. Prev Med. 2002;34:638–48.
Article
PubMed
Google Scholar
Helleve A, Henriksdatter Weisæth A, Lindbak R, Helleve A. HenriTal om tobakk 1973–2009 (Data on tobacco 1973–2009). Helsedirektoratet: Oslo; 2010.
Google Scholar
Hvitfeldt T, Nyström S. Centralförbundet för alkohol-och narkotikaupplysning. Stockholm: (CAN Report 114.); 2009.
Google Scholar
Rodu B, Nasic S, Cole P. Tobacco use among Swedish schoolchildren. Tob Control. 2005;14(6):405–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Norberg M, Lundqvist G, Nilsson M, Gilljam H, Weinehall L. Changing patterns of tobacco use in a middle-aged population – the role of snus, gender, age, and education. Glob Health Action. 2011;4.
Lee PN. Health risks related to dual use of cigarettes and snus - a systematic review. Regul Toxicol Pharmacol. 2014;69:125–34.
Article
PubMed
Google Scholar
Wikström AK, Stephansson O, Cnattingius S. Tobacco use during pregnancy and preeclampsia risk: effects of cigarette smoking and snuff. Hypertension. 2010;55:1254–9.
Article
CAS
PubMed
Google Scholar
Bates C, Fagerström K, Jarvis MJ, Kunze M, McNeill A, Ramström L. European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health. Tob Control. 2003;12:360–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Galanti MR, Rosendahl I, Wickholm S. The development of tobacco use in adolescence among "snus starters" and "cigarette starters": an analysis of the Swedish "BROMS" cohort. Nicotine Tob Res. 2008;10:315–23.
Article
PubMed
Google Scholar
Joffer J, Burell G, Bergström E, Stenlund H, Sjörs L, Jerdén L. Predictors of smoking among Swedish adolescents. BMC Public Health. 2014;14:1296.
Article
PubMed
PubMed Central
Google Scholar
Gmel G, Clair C, Rougemont-Bücking A, Grazioli VS, Daeppen JB, Mohler-Kuo M, Studer J. Snus and snuff use in Switzerland among young men: are there beneficial effects on smoking? Nicotine Tob Res. 2018;20:1301–9.
Article
PubMed
Google Scholar
Furberg H, Lichtenstein P, Pedersen NL, Bulik CM, Lerman C, Sullivan PF. Snus use and other correlates of smoking cessation in the Swedish Twin Registry. Psychol Med. 2008;38:1299–308.
Article
CAS
PubMed
PubMed Central
Google Scholar
Stenbeck M, Hagquist C, Rosén M. The association of snus and smoking behaviour: a cohort analysis of Swedish males in the 1990s. Addiction. 2009;104:1579–85.
Article
PubMed
Google Scholar
Lund KE, Scheffels J, McNeill A. The association between use of snus and quit rates for smoking: results from seven Norwegian cross-sectional studies. Addiction. 2011;106:162–7.
Article
PubMed
PubMed Central
Google Scholar
Rutgvist LE. Population-based survey of cessation aids used by Swedish smokers. Harm Reduct J. 2012;9:38.
Article
Google Scholar
Rodu B, Phillips CV. Switching to smokeless tobacco as a smoking cessation method: evidence from the 2000 National Health Interview Survey. Harm Reduct J. 2008;5:18.
Article
PubMed
PubMed Central
Google Scholar
Caldwell B, Burgess C, Crane J. Randomized crossover trial of the acceptability of snus, nicotine gum, and Zonnic therapy for smoking reduction in heavy smokers. Nicotine Tob Res. 2010;12:179–83.
Article
CAS
PubMed
Google Scholar
Joksić G, Spasojević-Tišma V, Antić R, Nilsson R, Rutqvist LE. Randomised, placebo-controlled, double-blind trial of Swedish snus for smoking reduction and cessation. Harm Reduct J. 2011;8:25.
Article
PubMed
PubMed Central
Google Scholar
Lindson-Hawley N, Hartmann-Boyce J, Fanshawe TR, Begh R, Farley A, Lancaster T. Interventions to reduce harm from continued tobacco use. Cochrane Database of Systematic Reviews 2016, Issue 10. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005231.pub3/pdf/CDSR/CD005231/CD005231.pdf. Accessed 16th July 2019.
Klimisch HJ, Andreae M, Tillmann U. A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. Regul Toxicol Pharmacol. 1997;25(1):1–5.
Article
CAS
PubMed
Google Scholar